Market Closed -
Nasdaq Stockholm
11:29:30 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
185.6
SEK
|
-2.73%
|
|
+0.76%
|
+3.40%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
3,158
|
4,717
|
4,948
|
7,650
|
6,050
|
6,301
|
Enterprise Value (EV)
1 |
3,620
|
6,128
|
6,248
|
8,616
|
7,457
|
7,603
|
P/E ratio
|
15.5
x
|
20.9
x
|
44.8
x
|
25.1
x
|
18.4
x
|
18.5
x
|
Yield
|
2.56%
|
-
|
0.71%
|
1.61%
|
2.18%
|
2.2%
|
Capitalization / Revenue
|
0.89
x
|
1.09
x
|
1.35
x
|
1.89
x
|
1.17
x
|
1.02
x
|
EV / Revenue
|
1.02
x
|
1.42
x
|
1.7
x
|
2.13
x
|
1.44
x
|
1.23
x
|
EV / EBITDA
|
11
x
|
15.8
x
|
16.8
x
|
18
x
|
14.2
x
|
9.72
x
|
EV / FCF
|
15.2
x
|
31.5
x
|
24.1
x
|
23.6
x
|
139
x
|
19.7
x
|
FCF Yield
|
6.57%
|
3.18%
|
4.14%
|
4.24%
|
0.72%
|
5.09%
|
Price to Book
|
2.53
x
|
3.42
x
|
3.8
x
|
4.45
x
|
2.77
x
|
2.66
x
|
Nbr of stocks (in thousands)
|
35,089
|
35,093
|
35,093
|
35,093
|
35,093
|
35,105
|
Reference price
2 |
90.00
|
134.4
|
141.0
|
218.0
|
172.4
|
179.5
|
Announcement Date
|
3/18/19
|
3/16/20
|
3/19/21
|
3/19/22
|
3/17/23
|
3/15/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
3,554
|
4,308
|
3,675
|
4,042
|
5,179
|
6,188
|
EBITDA
1 |
329.3
|
387.4
|
371.8
|
478.4
|
526
|
782.1
|
EBIT
1 |
295.1
|
344.4
|
322.1
|
429.8
|
462.1
|
617.8
|
Operating Margin
|
8.3%
|
7.99%
|
8.77%
|
10.63%
|
8.92%
|
9.98%
|
Earnings before Tax (EBT)
1 |
268
|
307.3
|
148.5
|
417.1
|
438.8
|
476.2
|
Net income
1 |
203.2
|
225.8
|
110.4
|
305.3
|
328.7
|
340.9
|
Net margin
|
5.72%
|
5.24%
|
3%
|
7.55%
|
6.35%
|
5.51%
|
EPS
2 |
5.790
|
6.430
|
3.146
|
8.700
|
9.367
|
9.710
|
Free Cash Flow
1 |
237.7
|
194.7
|
258.8
|
365.1
|
53.68
|
386.7
|
FCF margin
|
6.69%
|
4.52%
|
7.04%
|
9.03%
|
1.04%
|
6.25%
|
FCF Conversion (EBITDA)
|
72.18%
|
50.25%
|
69.6%
|
76.31%
|
10.2%
|
49.45%
|
FCF Conversion (Net income)
|
116.98%
|
86.21%
|
234.41%
|
119.58%
|
16.33%
|
113.45%
|
Dividend per Share
2 |
2.300
|
-
|
1.000
|
3.500
|
3.750
|
3.950
|
Announcement Date
|
3/18/19
|
3/16/20
|
3/19/21
|
3/19/22
|
3/17/23
|
3/15/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
462
|
1,411
|
1,299
|
966
|
1,407
|
1,301
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.404
x
|
3.642
x
|
3.495
x
|
2.018
x
|
2.674
x
|
1.664
x
|
Free Cash Flow
1 |
238
|
195
|
259
|
365
|
53.7
|
387
|
ROE (net income / shareholders' equity)
|
17.5%
|
17.3%
|
8.23%
|
20.2%
|
16.8%
|
15%
|
ROA (Net income/ Total Assets)
|
5.45%
|
4.91%
|
4.47%
|
5.98%
|
5.28%
|
6.11%
|
Assets
1 |
3,731
|
4,598
|
2,468
|
5,102
|
6,231
|
5,581
|
Book Value Per Share
2 |
35.60
|
39.30
|
37.10
|
48.90
|
62.30
|
67.60
|
Cash Flow per Share
2 |
13.20
|
12.70
|
13.30
|
15.40
|
20.60
|
23.20
|
Capex
1 |
23.7
|
42.8
|
34.3
|
39.2
|
70.7
|
104
|
Capex / Sales
|
0.67%
|
0.99%
|
0.93%
|
0.97%
|
1.37%
|
1.68%
|
Announcement Date
|
3/18/19
|
3/16/20
|
3/19/21
|
3/19/22
|
3/17/23
|
3/15/24
|
|
1st Jan change
|
Capi.
|
---|
| +3.40% | 594M | | +10.59% | 8.7B | | +29.45% | 2.21B | | -0.24% | 1.18B | | -2.50% | 808M | | -2.33% | 565M | | -14.90% | 600M | | -8.50% | 553M | | -0.15% | 501M | | -13.30% | 450M |
Purification & Treatment Equipment
|